UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 4 | April 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 8 Issue 2
February-2021
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2102098


Registration ID:
305497

Page Number

837-845

Share This Article


Jetir RMS

Title

The Role of Natural Nrf Activators in Respiratory Diseases

Abstract

Respiratory diseases are those which are related to airways and lung disorders. Nrf2 (67kDa pzip CNC transcription factor) nuclear erythroid 2-related factor is a transcription factor with complex multi- domain proteins which regulates the anti-oxidant response element (ARE) driven cyto protective protein expression. It is believed that Nrf2 activation reduces the systemic inflammation, lowers the oxidative stress and improves the mitochondrial function and this can be useful in treating various respiratory diseases like chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis(IPF), bronchopulmonary dysplasia (BPD), asthma, infection related to respiratory organs, acute respiratory distress syndrome(ARDS), lung cancer etc. Nrf2 activation helps to prevent the tissue or cell damage occurred by oxidative stress. under stress, kelch like ECH associated protein (cysteine rich protein), a natural inhibitor of Nrf2, traps Nrf2 in cytoplasm thus degrades Nrf2 by 26s proteosome. stress impairs the protein to target Nrf2 for ubiquitination, degrade and uses Nrf2 (newly synthesized) to translocate to nucleus and bind with ARE. These activators can be activated by exercise, fasting or by restriction calories or also by intake of natural nutrients. Nrf2 activators used commonly are Curcumin (lung cancer), anti-oxidants found in green tea, Resveratrol(Pneumococcal infections, ARDS,COPD, Lung cancer), vitamin E (Asthma), Sulforaphane (Asthma,IPF, lung cancer), Emodin (IPF, IAV infections), Quercetin (IPF), derivative BHBA(lung cancer), Cinnamaldehyde, Bixin,tBHQ (RSV infection, ARDS) etc.

Key Words

Nrf activator, Respiratory diseases, Sulforaphane, Asthma, COPD

Cite This Article

"The Role of Natural Nrf Activators in Respiratory Diseases", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 2, page no.837-845, February-2021, Available :http://www.jetir.org/papers/JETIR2102098.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"The Role of Natural Nrf Activators in Respiratory Diseases", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 2, page no. pp837-845, February-2021, Available at : http://www.jetir.org/papers/JETIR2102098.pdf

Publication Details

Published Paper ID: JETIR2102098
Registration ID: 305497
Published In: Volume 8 | Issue 2 | Year February-2021
DOI (Digital Object Identifier):
Page No: 837-845
Country: Phagwara, Punjab, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0003082

Print This Page

Current Call For Paper

Jetir RMS